Pilot implementation of the GAIHN point prevalence survey on healthcare-associated infections at a Jordanian tertiary oncology hospital, an international partnership with the U.S. Centers for Disease Control and Prevention
Sawsan Mubarak, Joud Jarrah, Manar Makhlouf, Rawan Hajir, Sulafa Al Ansari, Hebah Beides, Hadeel AlGhawrieAbstract
Background:
The Global Action in Healthcare Network develops point prevalence survey (PPS) protocol for healthcare-associated infection surveillance, particularly in resource-limited settings. This study reports the first field implementation of the Global Action in Healthcare Network (GAIHN) HAI PPS protocol and aims to evaluate the protocol and to estimate healthcare-associated infection (HAI) prevalence and antimicrobial use at a tertiary oncology hospital in Jordan.
Methods:
Descriptive, cross-sectional point prevalence survey conducted using a standardized GAIHN HAI PPS protocol, coordinated by the U.S. Centers for Disease Control and Prevention, was implemented using an algorithmic REDCap-based data collection system. Targeted HAIs included bloodstream infection, pneumonia, urinary tract infection, and surgical site infection. Antimicrobial use, device exposure, microbiology, and ward-level characteristics were recorded. HAI prevalence was calculated with 95% confidence intervals.
Results:
A total of 124 patients were surveyed, 73 (58.9%) underwent full chart review. Antimicrobial use was documented in 63.7% of surveyed patients, with an Access-to-Watch ratio of 0.23. Eight HAI events were identified in six patients, corresponding to an overall HAI prevalence of 4.8% (6/124; 95% CI 2.2–10.1). Pneumonia was the most frequent HAI type. Gram-negative organisms accounted for 60% of isolates. Patients in intensive care was more likely to meet criteria for detailed review.
Conclusion:
This pilot demonstrated feasibility for the GAIHN HAI PPS methodology and data collection system. It offers a framework for improving IPC programs and implementing evidence-based practices that can be adapted and scaled across the region, contributing to the global effort to reduce HAIs and combat antimicrobial resistance.